Race for Hope DC Raises Nearly $30 Million for Brain Tumor Research Over Its 20-Year History
Washington, D.C. (PRWEB) May 09, 2017 -- On Sunday May 7th, the 20th annual Race for Hope – DC, presented by Cushman & Wakefield, brought together nearly 10,000 brain cancer advocates raising $1.7 million to benefit Accelerate Brain Cancer Cure (ABC²) and the National Brain Tumor Society (NBTS).
These organizations, as well as all of the participants, survivors and volunteers, share the hope for a day when a cure for brain tumors exists. Since its inception 20 years ago, the Race for Hope - DC has raised over $29 million for brain tumor research and support for those affected by the disease.
“In its 20-year history, the Race for Hope has made a powerful and lasting contribution to the brain tumor community,” said Max Wallace, CEO of ABC². “The funds raised here help ABC² advance effective new treatments for brain cancer that would not move forward without our investment.”
“Race for Hope is an extremely powerful event to really kick-start Brain Tumor Awareness Month every May and generate positive momentum for the remainder of the month and, indeed, year,” said David Arons, CEO of NBTS. “We’re flexing our ‘muscles’ – our legs, our vocal chords and our hearts – in support of our shared cause, while raising proceeds that will help NBTS continue to drive strategic research, resource new clinical trials, and influence public policy in order to generate more treatment options that will improve the lives of brain tumor patients and their families.”
“The Race for Hope – DC brings together a dedicated community who all share a common goal: an end to brain cancer,” said David Cook, previous American Idol® winner and Honorary Chair of the Race for Hope – DC. Cook’s “Team for a Cure” has raised more than $1.2 million for the annual events.
“The Race for Hope DC is an extremely important cause for Cushman & Wakefield in the Washington metropolitan area,” said Roberta Liss, Regional Managing Principal, Northeast and Mid-Atlantic Regions, Cushman & Wakefield. “Our involvement started 17 years ago when one of our legacy firms’ co-founders, Pat Cassidy, fell ill with a brain tumor. While we lost Pat in 2001, our support of this cause has been unwavering ever since. On the 20thAnniversary, we are honored to serve as the presenting sponsor of the largest fundraiser for brain tumor research in the country.”
“The Race for Hope provides invaluable funding for the National Brain Tumor Society and ABC² as they fund new research and support for brain cancer patients,” Liss continued. “Together, we are making real progress towards a cure and improving the quality of life for brain tumor patients. Cushman & Wakefield wants to thank all of our friends and clients for their continuous support of our efforts.”
Highlights of the 20th annual Race for Hope - DC included a Survivor Tribute featuring more than 350 brain tumor survivors who marched together towards the start line as a symbol of hope and strength in their battle against brain tumors. The Race for Hope - DC is the culmination of a weekend of activities, including a benefit concert by David Cook at Jammin Java and many team-sponsored fundraising parties. These activities provide an opportunity for family and friends to honor and celebrate the lives of their loved ones, as well as provide support to each other.
This year’s Rabbi Joseph P. Weinberg Triumph of Spirit Award honored the Roth Family and Urban Country Design for creating the Wall of Hope – a 24-foot long tribute to brain tumor survivors and those who lost their battles.
Top sponsors include: Cushman & Wakefield, Holliday, Fenoglio and Fowler and the Conley Family; Cravath, Swaine & Moore LLP; R&R Mechanical; Genentech; The Case Foundation; Newmark Grubb Knight Frank; Normandy Real Estate Partners; M&T Bank; Urban Country; and Fresh FM 94.
Each year, the Race for Hope – DC helps to bring hope and attention to this often underserved brain tumor community. The need to increase research funding is more urgent than ever – there are almost 700,000 people living with a primary brain tumor diagnosis in the U.S. and within the next 12 months, more than 210,000 people in the United States will be diagnosed with a primary or metastatic brain tumor.
About ABC² (Accelerate Brain Cancer Cure)
ABC² is focused on speeding the discovery of a cure for brain cancer. By applying an aggressive, venture funding approach not typically seen in the nonprofit sector, ABC² closes current gaps in funding in order to catalyze research and rapidly bring new therapies to patients. ABC² has awarded more than 100 grants totaling $20 million in brain tumor research funding to highly qualified investigators and physician-scientists from 54 institutions and companies. To learn more, visit http://www.abc2.org.
About National Brain Tumor Society
National Brain Tumor Society (NBTS) is the largest nonprofit organization in the U.S. dedicated to the brain tumor community. We are fiercely committed to finding better treatments and driving rapid progress toward a cure for brain tumors. We drive a multi-faceted and thoughtful approach to aggressively influence and fund strategic research, as well as advocate for public policy changes, in order to achieve the greatest impact, results, and progress for brain tumor patients. Money raised by the generous donations of our supporters has directly funded groundbreaking discoveries, programs, clinical trials and policy initiatives. To learn more visit http://www.braintumor.org
About Cushman & Wakefield
Cushman & Wakefield is a leading global real estate services firm that helps clients transform the way people work, shop, and live. Our 45,000 employees in more than 70 countries help occupiers and investors optimize the value of their real estate by combining our global perspective and deep local knowledge with an impressive platform of real estate solutions. Cushman & Wakefield is among the largest commercial real estate services firms with revenue of $6 billion across core services of agency leasing, asset services, capital markets, facility services (C&W Services), global occupier services, investment & asset management (DTZ Investors), project & development services, tenant representation, and valuation & advisory. 2017 marks the 100-year anniversary of the Cushman & Wakefield brand. 100 years of taking our clients’ ideas and putting them into action. To learn more, visit http://www.cushwakecentennial.com, http://www.cushmanwakefield.com or follow @CushWake on Twitter.
Nicola Beddow, ABC² (Accelerate Brain Cancer Cure), http://www.abc2.org, +1 202-467-2051, [email protected]
Share this article